Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Fluphenazine decanoate
Drug ID BADD_D00936
Description A phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of chlorpromazine.
Indications and Usage For management of manifestations of psychotic disorders.
Marketing Status Prescription; Discontinued
ATC Code N05AB02
DrugBank ID DB00623
KEGG ID D00793
MeSH ID C011825
PubChem ID 3388
TTD Drug ID D03NTJ
NDC Product Code 51927-2234; 55150-267; 42023-129; 0143-9529; 67457-359; 71277-0127; 51927-0114; 63323-272; 48954-458; 71052-024; 71277-0125; 69766-073; 67763-123
Synonyms fluphenazine depot | fluphenazine decanoate | ftorphenazine decanoate | mirenil | moditen depot | moditen-depot | liogen | modecate
Chemical Information
Molecular Formula C32H44F3N3O2S
CAS Registry Number 5002-47-1
SMILES CCCCCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hypothermia12.05.03.001; 08.05.01.003--
Ileus paralytic07.02.05.001--Not Available
Jaundice cholestatic09.01.01.005--Not Available
Labile blood pressure24.06.01.001--Not Available
Laryngeal oedema23.04.01.005; 22.04.02.001; 10.01.05.003--
Lethargy17.02.04.003; 08.01.01.008; 19.04.04.004--
Leukocytosis01.02.01.002--
Leukopenia01.02.02.001--Not Available
Libido increased21.03.02.007; 19.08.03.002--
Loss of consciousness17.02.04.004--Not Available
Menorrhagia21.01.03.002--
Menstruation irregular05.05.01.008; 21.01.01.005--
Mitral valve incompetence02.07.01.002--Not Available
Muscle rigidity17.05.02.005; 15.05.04.001--Not Available
Muscle spasms15.05.03.004--
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Neurogenic bladder20.03.03.001; 17.10.01.002--Not Available
Neuroleptic malignant syndrome17.05.02.003; 15.05.04.015; 12.03.01.003; 08.05.01.005--Not Available
Night blindness06.02.02.003; 14.12.03.001--
Oculogyric crisis17.01.03.002; 06.05.02.002--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Opisthotonus17.01.03.005--Not Available
Pain08.01.08.004--
Pancytopenia01.03.03.003--Not Available
Parkinsonism17.01.05.003--Not Available
Photosensitivity reaction23.03.09.003--
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Pneumonitis22.01.01.006--
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages